<scp>M</scp> et <scp>ALD</scp> : Diagnosis and Prognosis With Non‐Invasive Tests
Widely available NITs are applicable for MetALD, where cut-offs can be used to diagnose advanced fibrosis and predict clinical outcomes.
Authors
- Camilla Dalby Hansen (ORCID: https://orcid.org/0000-0002-5704-2485)
- Katrine Holtz Thorhauge (ORCID: https://orcid.org/0000-0003-0411-0373)
- Peter Andersen (ORCID: https://orcid.org/0009-0001-4278-3731)
- K. Bech (ORCID: https://orcid.org/0000-0002-3760-0689)
- Emmanuel Tsochatzis (ORCID: https://orcid.org/0000-0001-5069-2461)
- Katrine Prier Lindvig (ORCID: https://orcid.org/0000-0001-7891-7706)
- Mads Israelsen (ORCID: https://orcid.org/0000-0001-9443-5846)
- Ida Falk Villesen (ORCID: https://orcid.org/0000-0001-7921-9707)
- Stine Johansen (ORCID: https://orcid.org/0000-0002-5031-2294)
- Aleksander Krag (ORCID: https://orcid.org/0000-0002-9598-4932)
- Nikolaj Torp (ORCID: https://orcid.org/0000-0002-4378-6256)
- M.A. Karsdal (ORCID: https://orcid.org/0000-0001-5026-8740)
- Maja Thiele (ORCID: https://orcid.org/0000-0003-1854-1924)
- Georg Semmler (ORCID: https://orcid.org/0000-0002-0411-166X)
- Helle Lindholm Schnefeld (ORCID: https://orcid.org/0009-0009-6566-9681)
- Mette Lehmann Andersen
- Emil Deleuran Hansen
- Ellen Lyngbeck Jensen
Institutions
- University of Southern Denmark (DK)
- The Royal Free Hospital (GB)
- Odense University Hospital (DK)
- Herlev Hospital (DK)
- Nordic Bioscience (Denmark) (DK)
- University College London (GB)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1111/apt.70281
- Citations
- 6
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- AstraZeneca
- European Commission
- Novo Nordisk
- Novo Nordisk Fonden
- Norgine
- Horizon 2020 Framework Programme